AnyCare uses new screening for sleep apnea
17.08.2012 12:48
Nocturnal pauses in breathing not only disrupt restful sleep, they can also result in heart attacks, strokes or accidents. A new screening from AnyCare GmbH is now determining whether people suffer from “sleep apnea” and pauses in breathing. Insured people with suspected sleep-related breathing disorders should benefit from this. AnyCare is now offering the health insurance and insurance program. Participants receive a device specially developed by Weinmann Geräte für Medizin GmbH and Co. KG, which monitors breathing and detects existing sleep disorders. AnyCare’s medical staff will evaluate the data. Information and telephone advice with tips on the clinical picture round off the screening, which is free for patients.
Around three percent of the German population suffers from sleep apnea, especially middle-aged men. Breathing stops, so-called apneas, often occur during sleep. The sleep apnea specialist association estimates that around we
Around three percent of the German population suffers from sleep apnea, especially middle-aged men. Breathing stops, so-called apneas, often occur during sleep. The Sleep Apnea Association estimates that another three million people in this country have not yet received treatment or do not know anything about their disease. Due to the pauses in breathing, the body is temporarily insufficiently supplied with oxygen, which ultimately puts a strain on the cardiovascular system. Over time, this can lead to a heart attack or stroke. In addition, restful sleep is disrupted: those affected are often tired during the day, unable to concentrate or fall asleep involuntarily - known as microsleep. This can lead to more accidents. In addition to severe daytime tiredness, a typical symptom of sleep apnea is loud snoring. Sleep apnea is often associated with obesity and comorbidities such as type 2 diabetes or high blood pressure.
Patients who take part in the screening program receive a special diagnostic device that they wear around their wrist like a watch. The device records the relevant vital parameters of those affected overnight. The medical specialists at AnyCare GmbH then evaluate the data and inform the patients about their results. If necessary, patients are then referred to their primary care doctor. “The screening device allows a differentiated and high-quality statement about the sleep quality of those affected. Through timely and professional evaluation, we can quickly and reliably identify existing sleep disorders,” says Dr. Thorsten Pilgrim, spokesman for the management of AnyCare GmbH. The appropriate treatment can be carried out in a targeted manner depending on the severity of the sleep apnea.
There are three million people in this country who have not yet received treatment or do not know anything about their illness. Due to the pauses in breathing, the body is temporarily insufficiently supplied with oxygen, which ultimately puts a strain on the cardiovascular system. Over time, this can lead to a heart attack or stroke. In addition, restful sleep is disrupted: those affected are often tired during the day, unable to concentrate or fall asleep involuntarily - known as microsleep. This can lead to more accidents. In addition to severe daytime tiredness, a typical symptom of sleep apnea is loud snoring. Sleep apnea is often associated with obesity and comorbidities such as type 2 diabetes or high blood pressure.
Patients who take part in the screening program receive a special diagnostic device that they wear around their wrist like a watch. The device records the relevant vital parameters of those affected overnight. The medical specialists at AnyCare GmbH then evaluate the data and inform the patients about their results. If necessary, patients are then referred to their primary care doctor. “The screening device allows a differentiated and high-quality statement about the sleep quality of those affected. Through timely and professional evaluation, we can quickly and reliably identify existing sleep disorders,” says Dr. Thorsten Pilgrim, spokesman for the management of AnyCare GmbH. The appropriate treatment can be carried out in a targeted manner depending on the severity of the sleep apnea.